ENTASIS THERAPEUTICS HLDGS I's ticker is ETTX and the CUSIP is 293614103. A total of 30 filers reported holding ENTASIS THERAPEUTICS HLDGS I in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,106,000 | +22.2% | 502,622 | +3.9% | 0.00% | – |
| Q1 2022 | $905,000 | -8.2% | 483,723 | +7.5% | 0.00% | – |
| Q4 2021 | $986,000 | -30.8% | 449,955 | +5.6% | 0.00% | – |
| Q3 2021 | $1,424,000 | +27.0% | 426,235 | +1.5% | 0.00% | – |
| Q2 2021 | $1,121,000 | +155.4% | 419,997 | +104.7% | 0.00% | – |
| Q1 2021 | $439,000 | +33.4% | 205,166 | +54.1% | 0.00% | – |
| Q4 2020 | $329,000 | +63.7% | 133,159 | +34.8% | 0.00% | – |
| Q3 2020 | $201,000 | +24.8% | 98,759 | +81.1% | 0.00% | – |
| Q2 2020 | $161,000 | +11.8% | 54,526 | 0.0% | 0.00% | – |
| Q1 2020 | $144,000 | -46.9% | 54,526 | 0.0% | 0.00% | – |
| Q4 2019 | $271,000 | -14.8% | 54,526 | 0.0% | 0.00% | – |
| Q3 2019 | $318,000 | +0.3% | 54,526 | +11.1% | 0.00% | – |
| Q2 2019 | $317,000 | -4.5% | 49,097 | 0.0% | 0.00% | – |
| Q1 2019 | $332,000 | +66.0% | 49,097 | 0.0% | 0.00% | – |
| Q4 2018 | $200,000 | – | 49,097 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eventide Asset Management | 590,602 | $1,577,000 | 0.02% |
| TPG Group Holdings (SBS) Advisors, Inc. | 1,020,748 | $2,725,000 | 0.02% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 23,058 | $62,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 110,000 | $294,000 | 0.01% |
| Alberta Investment Management Corp | 130,000 | $347,000 | 0.00% |
| Jaffetilchin Investment Partners, LLC | 11,000 | $29,000 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 164,229 | $438,000 | 0.00% |
| TWO SIGMA ADVISERS, LP | 162,942 | $435,000 | 0.00% |
| Janney Montgomery Scott LLC | 69,487 | $186,000 | 0.00% |
| Renaissance Technologies | 391,629 | $1,046,000 | 0.00% |